Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatebioAffinity Technologies, Inc. Common Stock
XNAS•Health Care•Services-Commercial Physical & Biological Research
Flagged at $5.34 at 07:03 AM on Sep 17, then ran to $11.00 +106% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is BIAF down today? It is at $6.02 (-0.66%), and our scanner flagged it 231 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BIAF spikes, and full due diligence on BIAF — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BIAF 231 times in the last 30 days. Create a free account to track $BIAF, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
BIAF is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on BIAF today, peaking at 6.8x its normal volume. Fresh from the SEC: bioAffinity Technologies, Inc.: Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-commercial physical & biological research, closest in size first.
BIAF is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on BIAF today, peaking at 6.8x its normal volume. Fresh from the SEC: bioAffinity Technologies, Inc.: Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
BIAF last traded at $6.02, down 0.66% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
bioAffinity Technologies, Inc. Common Stock (BIAF) is next expected to report earnings on Friday, November 13, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BIAF Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BIAF 231 times in the last 30 days.
BIAF (bioAffinity Technologies, Inc. Common Stock) trades on XNAS, with a market cap of about $49M in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BIAF for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BIAF discussion
Sign in to ask a question or join the discussion.